Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India flag India · Delayed Price · Currency is INR
153.09
-0.84 (-0.55%)
Aug 21, 2026, 3:29 PM IST

Nath Bio-Genes (India) Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-759.95888.99774.1379.9541.81
Cash & Short-Term Investments
759.95759.95888.99774.1379.9541.81
Cash Growth
-14.52%-14.52%14.84%103.73%808.85%-85.69%
Accounts Receivable
-854.15889.02943.09973.14855.48
Other Receivables
-9.7972.7164.0863.6871.79
Receivables
-863.94961.721,0071,037927.27
Inventory
-4,5053,3802,3032,0782,203
Prepaid Expenses
--4.292.93.63.48
Other Current Assets
-1,6591,6651,6291,6991,502
Total Current Assets
-7,7896,9005,7175,1984,678
Property, Plant & Equipment
-2,4382,4322,4062,3402,329
Long-Term Investments
-59.0257.8260.4650.4850.48
Other Intangible Assets
-55.8671.8288.12104.17120.26
Other Long-Term Assets
-426.41442.16421.59235.4217.86
Total Assets
-10,97410,2628,8027,9287,395

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-1,311794.84432.96277.36427.82
Accrued Expenses
-8.55139.11104.3197.99117
Short-Term Debt
-1,21248.7849.1210.3318.84
Current Portion of Long-Term Debt
--1,0461,0061,038904.1
Current Income Taxes Payable
-14.623.99.472.818.87
Current Unearned Revenue
--1,142645.95513.23238.37
Other Current Liabilities
-1,401478.42376.96224.87227.91
Total Current Liabilities
-3,9473,6532,6242,1641,943
Long-Term Debt
-173.22129.7648.654.036.65
Pension & Post-Retirement Benefits
-49.4735.433022.3518.39
Other Long-Term Liabilities
--0--05.527.71
Total Liabilities
-4,1703,8182,7032,1961,976

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-190.04190.04190.04190.04190.04
Additional Paid-In Capital
--1,3351,3351,3351,335
Retained Earnings
--4,7924,4444,0863,774
Comprehensive Income & Other
-6,615126.4129.7120.43120.22
Total Common Equity
6,8056,8056,4446,0995,7325,419
Minority Interest
------0.05
Shareholders' Equity
6,8056,8056,4446,0995,7325,419
Total Liabilities & Equity
-10,97410,2628,8027,9287,395

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
1,3851,3851,2251,1031,052929.59
Net Cash (Debt)
-625.06-625.06-336.01-329.36-672.17-887.78
Net Cash Growth
------
Net Cash Per Share
-31.50-31.50-17.68-17.33-35.37-46.72
Filing Date Shares Outstanding
1922.3619191919
Total Common Shares Outstanding
1922.3619191919
Working Capital
-3,8423,2473,0923,0342,735
Book Value Per Share
304.35304.35339.08320.94301.61285.16
Tangible Book Value
6,7496,7496,3726,0115,6285,299
Tangible Book Value Per Share
301.86301.86335.30316.31296.12278.84
Land
--2,2252,2212,2212,221
Buildings
--60.5248.6733.7831.28
Machinery
--342.95311.9280.98260.2